Frank W. Seibold
Bern, BE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Early transmural response assessed by intestinal ultrasound predicts long-term clinical remission in patients with IBD: Results from the TRUST BEYOND study.
Journal: Inflammatory bowel diseases
Published: October 01, 2025
Fecal Incontinence in Inflammatory Bowel Disease (IBD): Associated Factors and Impact on the Quality of Life of Patients in an IBD Clinic in Switzerland.
Journal: Cureus
Published: August 14, 2025
Nutrient excess remodels islet autonomic innervation via pancreatic schwann cells.
Journal: bioRxiv : the preprint server for biology
Published: July 09, 2025
Successful peroral cholangioscopic extraction of migrated endovascular coils into the bile ducts 2 years following right hepatic artery pseudoaneurysm endovascular treatment.
Journal: VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy
Published: September 05, 2024
Bone health in patients with inflammatory bowel disease.
Journal: Swiss medical weekly
Published: June 14, 2024
Fecal urgency and incontinence in inflammatory bowel disease perceived by physician and patient: Results from the Swiss fecal urgency survey.
Journal: United European gastroenterology journal
Published: May 09, 2024
SARS-CoV-2 vaccination in inflammatory bowel disease patients is not associated with flares: a retrospective single-centre Swiss study.
Journal: Annals of medicine
Published: January 30, 2024
Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice.
Journal: Swiss medical weekly
Published: September 28, 2023
Survey of dietary beliefs and habits of inflammatory bowel disease patients.
Journal: Clinical nutrition ESPEN
Published: March 10, 2023
Transoral Outlet Reduction (TORe) for the Treatment of Weight Regain and Dumping Syndrome after Roux-en-Y Gastric Bypass.
Journal: Medicina (Kaunas, Lithuania)
Published: November 30, 2022
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial.
Journal: Lancet (London, England)
Published: December 18, 2020
Last Updated: 09/26/2026